S A Older1, D F Battafarano, R J Enzenauer, A M Krieg. 1. Rheumatology Service, Brooke Army Medical Center, and Veterans Affairs Medical Center and Department of Medicine, University of Iowa, USA.
Abstract
OBJECTIVES: To report a series of five patients who developed systemic lupus erythematosus (SLE) after immunization and review the literature on vaccine-associated connective tissue diseases and the theoretical mechanisms that could explain such an association. METHODS: Uncontrolled retrospective analysis of cases identified sporadically over 7 years at three centers. RESULTS: In our series of 5 patients, symptoms of SLE developed within 2 to 3 weeks after secondary immunization. All patients met American College of Rheumatology (ACR) criteria for the diagnosis of SLE. In most patients, symptoms have been persistent. CONCLUSION: Although a coincidental association between vaccination and the onset of SLE cannot be excluded, the temporal relationship with the development of symptoms makes it immunologically plausible that vaccination triggered systemic autoimmunity in these rare cases. We propose that epidemiological studies be performed to examine this potential association in more detail to quantitate the risk and identify possible genetic risk factors.
OBJECTIVES: To report a series of five patients who developed systemic lupus erythematosus (SLE) after immunization and review the literature on vaccine-associated connective tissue diseases and the theoretical mechanisms that could explain such an association. METHODS: Uncontrolled retrospective analysis of cases identified sporadically over 7 years at three centers. RESULTS: In our series of 5 patients, symptoms of SLE developed within 2 to 3 weeks after secondary immunization. All patients met American College of Rheumatology (ACR) criteria for the diagnosis of SLE. In most patients, symptoms have been persistent. CONCLUSION: Although a coincidental association between vaccination and the onset of SLE cannot be excluded, the temporal relationship with the development of symptoms makes it immunologically plausible that vaccination triggered systemic autoimmunity in these rare cases. We propose that epidemiological studies be performed to examine this potential association in more detail to quantitate the risk and identify possible genetic risk factors.
Authors: I Fomin; D Caspi; V Levy; N Varsano; Y Shalev; D Paran; D Levartovsky; I Litinsky; I Kaufman; I Wigler; E Mendelson; O Elkayam Journal: Ann Rheum Dis Date: 2005-07-13 Impact factor: 19.103
Authors: Martin Feuchtenberger; Stefan Kleinert; Sven Schwab; Petra Roll; Eva Christina Scharbatke; Eva Ostermeier; Reinhard E Voll; Arne Schäfer; Hans-Peter Tony Journal: Rheumatol Int Date: 2011-02-15 Impact factor: 2.631
Authors: Zhenhuan Zhao; Jiling Ren; Chao Dai; Carol C Kannapell; Hongyang Wang; Felicia Gaskin; Shu Man Fu Journal: Ann Rheum Dis Date: 2018-09-25 Impact factor: 19.103